The toxic effect of arsenic on the living cell probably follows the combination of the arsenic with certain vital components of the cell (1 to 5, 8). This combination has been observed to be reversible in vitro (5 to 9). With the development of 2,3-dimercaptopropanol (BAL) by Peters, Stocken, and Thompson (8), the detoxification of arsenic by dissociation of the arsenic-cell complex seemed feasible in man, since BAL has the requisite affinity for arsenic without undue toxicity (8 to 10). BAL was therefore administered in ointment, and later by injection, in the treatment of arsenical intoxication (11, 12).
The toxic effect of arsenic on the living cell probably follows the combination of the arsenic with certain vital components of the cell (1 to 5, 8) . This combination has been observed to be reversible in vitro (5 to 9). With the development of 2,3-dimercaptopropanol (BAL) by Peters, Stocken, and Thompson (8) , the detoxification of arsenic by dissociation of the arsenic-cell complex seemed feasible in man, since BAL has the requisite affinity for arsenic without undue toxicity (8 to 10). BAL was therefore administered in ointment, and later by injection, in the treatment of arsenical intoxication (11, 12 ).
An increased elimination of arsenic from the body during BAL treatment would probably reflect the release of a significant amount of arsenic from the cells (8, 10) . To test this point, the urinary excretion of arsenic has been followed before and during treatment with BAL in 18 patients in this clinic. Sixteen were suffering from a complication of arsenical therapy. The effect of BAL on these patients' course is described in another report (11) . The other 2 patients, who had received mapharsen without untoward reaction, were studied to determine the effect of BAL administered 2 and 3 days after an injection of the arsenical drug. The effect of BAL on the fecal excretion of arsenic was not followed, since the brief control period and the illness of the patients prevented the collection of accurately timed speciments.
METHODS
Arsenic in the urine was determined by the method of Magnuson and Watson (13 (14) . BAL was given intramuscularly in 5 or 10 per cent concentration in peanut oil and benzyl benzoate (10) .
Urinary sulfur was measured by the gravimetric procedures of Folin and Benedict (17) .
The titration of urine with iodine was performed at a strongly acid reaction. Approximately (Table I, Figures 1, 2 , and 3). One of these patients, after responding to 2 series of BAL injections, showed an increased excretion of arsenic following a 3-days course of inunction with BAL in ointment, but gave no clear response to a subsequent single, large inunction ( Figure   3 ). The total courses of treatment numbered 14 in 8 patients, with increased arsenic excretion in 13 trials in 8 patients.
In contrast to the findings in dermatitis, only 3 of the 6 patients with jaundice showed an increased excretion of arsenic after a course of 534 The effect of the route of administration of BAL on the excretion of arsenic cannot be evaluated because of the small number and diversity of the cases. It is evident that either inunction or injection of BAL is generally quite effective. The dosage by inunction was usually larger.
A few experiments were undertaken to observe the relation between urinary sulfur and arsenic during the administration of BAL. In 3 patients, excretion of organic sulfur increased after BAL (Figures 4 and 5) . In each case, the excretion of arsenic was affected to a greater or less degree by the administration of BAL, and the change coincided with an increase of organic sulfur in the urine. The reverse effect could not be demonstrated in 2 cases ( Figure 5 ) in which an injection of mapharsen did not appreciably affect the excretion of organic sulfur.
As a rough measurement of the addition of reduced sulfur to the urine after the administration of BAL, the iodine uptake of strongly acidified urine was measured. This quantity, recorded as m. eq. of iodine per day, increased after BAL treatment and closely followed the changes of arsenic excretion in 2 cases (Figures 4 and 6 ).
DISCUSSION
The consistent increase in arsenic excretion after BAL treatment of arsenical dermatitis corresponds with the good clinical response of these patients (11) . Although it is apparent that some arsenic is removed by the BAL, the excretion of arsenic continues at a lower level after the completion of treatment. There are reasons to believe that the arsenic removed by BAL is that which is most damaging. The combination of the skin with highly toxic arsenicals has been demonstrated to be reversible by BAL (8, 9) . BAL has been shown to restore cellular ferments of the skin inactivated by toxic arsenicals (8, 9) . Furthermore, the most toxic arsenical compounds, which are bound most firmly to the living cell, show the greatest stimulation of excretion after BAL (3, 10) . These observations suggest that the increase in urinary arsenic after BAL treatment reflects the release of a toxic arsenical from the skin, with consequent improvement of the dermatitis.
No such regular improvement is evident, either The patient received 2 courses of intramuscular injections of BAL. Subsequently, she was given a brief course of inunction with BAL in ointnent and finally a single large inunction. DcC, ately increased in the other 3. It is difficult to assess the etiologic role of arsenic in these cases, since intercurrent hepatitis would produce much the same picture (15 The increase in urinary arsenic after BAL appears to be more consistent in patients with the arsenical dermatitis than in hepatitis, suggesting a correlation with the greater efficacy of BAL in the treatment of arsenical dermatitis.
The increases of urinary organic sulfur and reducing substances coincide with the increased urinary arsenic after BAL administration, lending support to the idea that the excretion of BAL or a related substance is associated with the increased arsenic excretion.
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